Amarin News

Amarin's Sell Rating Affirmed Amid Declining U.S. Sales and Uncertain International Expansion

TipRanksMar 1 01:35

Analysts Offer Insights on Healthcare Companies: Shockwave Medical (SWAV), Amarin (AMRN) and Mereo Biopharma Group Plc (MREO)

TipRanksJan 15 13:10

Analysts' Opinions Are Mixed on These Healthcare Stocks: Tecan Group AG (OtherTCHBF) and Amarin (AMRN)

TipRanksJan 11 09:50

Amarin Corp Analyst Ratings

BenzingaNov 20, 2023 21:19

Analysts' Opinions Are Mixed on These Healthcare Stocks: Humana (HUM), Ocular Therapeutix (OCUL) and Amarin (AMRN)

TipRanksNov 6, 2023 15:20

Jefferies Downgrades Amarin Corp to Hold, Lowers Price Target to $1

BenzingaOct 25, 2023 19:17

Amarin Corp Analyst Ratings

BenzingaOct 25, 2023 19:14

Amarin Corp Analyst Ratings

BenzingaJul 20, 2023 20:04

Northland Adjusts Price Target on Amarin to $1.25 From $2, Maintains Market Perform Rating

MT NewswiresJul 19, 2023 22:14

Northland Capital Markets Maintains Market Perform on Amarin Corp, Lowers Price Target to $1.25

BenzingaJul 19, 2023 22:02

Amarin Corp Analyst Ratings

BenzingaJul 19, 2023 22:01

Analysts Offer Insights on Healthcare Companies: Amarin (AMRN) and Myriad Genetics (MYGN)

TipRanksMay 6, 2023 02:26

Analysts Offer Insights on Healthcare Companies: Amarin (AMRN), Ascendis Pharma (ASND) and MoonLake Immunotherapeutics (MLTX)

TipRanksApr 5, 2023 15:20

SVB Securities Sticks to Their Hold Rating for Amarin (AMRN)

TipRanksMar 3, 2023 13:21

Analysts Offer Insights on Healthcare Companies: InMode (INMD), Fulcrum Therapeutics (FULC) and Amarin (AMRN)

TipRanksJan 16, 2023 13:25

H.C. Wainwright Remains a Hold on Amarin (AMRN)

TipRanksOct 28, 2022 18:35

SVB Securities Adjusts Amarin's Price Target to $2 From $3, Maintains Market Perform Rating

MT NewswiresOct 20, 2022 00:48